img

Global KI-67 Antibody Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global KI-67 Antibody Market Research Report 2024

According to Mr Accuracy reports new survey, global KI-67 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole KI-67 Antibody market research.
Key companies engaged in the KI-67 Antibody industry include BD Biosciences, Thermo Fisher Scientific, Miltenyi Biotec, Merck, Miltenyi Biotec, Atlas Antibodies, Proteintech, FineTest and Synaptic, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of KI-67 Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole KI-67 Antibody market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global KI-67 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


BD Biosciences
Thermo Fisher Scientific
Miltenyi Biotec
Merck
Miltenyi Biotec
Atlas Antibodies
Proteintech
FineTest
Synaptic
United States Biological
Bio-Rad
Beckman Coulter
Leica Biosystems
NSJ Bioreagents
Segment by Type
Polyclonal
Monoclonal

Segment by Application


Immunofluorescence
Immunohistochemistry Frozen
Immunohistochemistry Paraffin
Western Blot
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The KI-67 Antibody report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global KI-67 Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global KI-67 Antibody Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Immunofluorescence
1.3.3 Immunohistochemistry Frozen
1.3.4 Immunohistochemistry Paraffin
1.3.5 Western Blot
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global KI-67 Antibody Market Perspective (2018-2029)
2.2 KI-67 Antibody Growth Trends by Region
2.2.1 Global KI-67 Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 KI-67 Antibody Historic Market Size by Region (2018-2024)
2.2.3 KI-67 Antibody Forecasted Market Size by Region (2024-2029)
2.3 KI-67 Antibody Market Dynamics
2.3.1 KI-67 Antibody Industry Trends
2.3.2 KI-67 Antibody Market Drivers
2.3.3 KI-67 Antibody Market Challenges
2.3.4 KI-67 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top KI-67 Antibody Players by Revenue
3.1.1 Global Top KI-67 Antibody Players by Revenue (2018-2024)
3.1.2 Global KI-67 Antibody Revenue Market Share by Players (2018-2024)
3.2 Global KI-67 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by KI-67 Antibody Revenue
3.4 Global KI-67 Antibody Market Concentration Ratio
3.4.1 Global KI-67 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by KI-67 Antibody Revenue in 2022
3.5 KI-67 Antibody Key Players Head office and Area Served
3.6 Key Players KI-67 Antibody Product Solution and Service
3.7 Date of Enter into KI-67 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 KI-67 Antibody Breakdown Data by Type
4.1 Global KI-67 Antibody Historic Market Size by Type (2018-2024)
4.2 Global KI-67 Antibody Forecasted Market Size by Type (2024-2029)
5 KI-67 Antibody Breakdown Data by Application
5.1 Global KI-67 Antibody Historic Market Size by Application (2018-2024)
5.2 Global KI-67 Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America KI-67 Antibody Market Size (2018-2029)
6.2 North America KI-67 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America KI-67 Antibody Market Size by Country (2018-2024)
6.4 North America KI-67 Antibody Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe KI-67 Antibody Market Size (2018-2029)
7.2 Europe KI-67 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe KI-67 Antibody Market Size by Country (2018-2024)
7.4 Europe KI-67 Antibody Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific KI-67 Antibody Market Size (2018-2029)
8.2 Asia-Pacific KI-67 Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific KI-67 Antibody Market Size by Region (2018-2024)
8.4 Asia-Pacific KI-67 Antibody Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America KI-67 Antibody Market Size (2018-2029)
9.2 Latin America KI-67 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America KI-67 Antibody Market Size by Country (2018-2024)
9.4 Latin America KI-67 Antibody Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa KI-67 Antibody Market Size (2018-2029)
10.2 Middle East & Africa KI-67 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa KI-67 Antibody Market Size by Country (2018-2024)
10.4 Middle East & Africa KI-67 Antibody Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD Biosciences
11.1.1 BD Biosciences Company Detail
11.1.2 BD Biosciences Business Overview
11.1.3 BD Biosciences KI-67 Antibody Introduction
11.1.4 BD Biosciences Revenue in KI-67 Antibody Business (2018-2024)
11.1.5 BD Biosciences Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific KI-67 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in KI-67 Antibody Business (2018-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Miltenyi Biotec
11.3.1 Miltenyi Biotec Company Detail
11.3.2 Miltenyi Biotec Business Overview
11.3.3 Miltenyi Biotec KI-67 Antibody Introduction
11.3.4 Miltenyi Biotec Revenue in KI-67 Antibody Business (2018-2024)
11.3.5 Miltenyi Biotec Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck KI-67 Antibody Introduction
11.4.4 Merck Revenue in KI-67 Antibody Business (2018-2024)
11.4.5 Merck Recent Development
11.5 Miltenyi Biotec
11.5.1 Miltenyi Biotec Company Detail
11.5.2 Miltenyi Biotec Business Overview
11.5.3 Miltenyi Biotec KI-67 Antibody Introduction
11.5.4 Miltenyi Biotec Revenue in KI-67 Antibody Business (2018-2024)
11.5.5 Miltenyi Biotec Recent Development
11.6 Atlas Antibodies
11.6.1 Atlas Antibodies Company Detail
11.6.2 Atlas Antibodies Business Overview
11.6.3 Atlas Antibodies KI-67 Antibody Introduction
11.6.4 Atlas Antibodies Revenue in KI-67 Antibody Business (2018-2024)
11.6.5 Atlas Antibodies Recent Development
11.7 Proteintech
11.7.1 Proteintech Company Detail
11.7.2 Proteintech Business Overview
11.7.3 Proteintech KI-67 Antibody Introduction
11.7.4 Proteintech Revenue in KI-67 Antibody Business (2018-2024)
11.7.5 Proteintech Recent Development
11.8 FineTest
11.8.1 FineTest Company Detail
11.8.2 FineTest Business Overview
11.8.3 FineTest KI-67 Antibody Introduction
11.8.4 FineTest Revenue in KI-67 Antibody Business (2018-2024)
11.8.5 FineTest Recent Development
11.9 Synaptic
11.9.1 Synaptic Company Detail
11.9.2 Synaptic Business Overview
11.9.3 Synaptic KI-67 Antibody Introduction
11.9.4 Synaptic Revenue in KI-67 Antibody Business (2018-2024)
11.9.5 Synaptic Recent Development
11.10 United States Biological
11.10.1 United States Biological Company Detail
11.10.2 United States Biological Business Overview
11.10.3 United States Biological KI-67 Antibody Introduction
11.10.4 United States Biological Revenue in KI-67 Antibody Business (2018-2024)
11.10.5 United States Biological Recent Development
11.11 Bio-Rad
11.11.1 Bio-Rad Company Detail
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad KI-67 Antibody Introduction
11.11.4 Bio-Rad Revenue in KI-67 Antibody Business (2018-2024)
11.11.5 Bio-Rad Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Detail
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter KI-67 Antibody Introduction
11.12.4 Beckman Coulter Revenue in KI-67 Antibody Business (2018-2024)
11.12.5 Beckman Coulter Recent Development
11.13 Leica Biosystems
11.13.1 Leica Biosystems Company Detail
11.13.2 Leica Biosystems Business Overview
11.13.3 Leica Biosystems KI-67 Antibody Introduction
11.13.4 Leica Biosystems Revenue in KI-67 Antibody Business (2018-2024)
11.13.5 Leica Biosystems Recent Development
11.14 NSJ Bioreagents
11.14.1 NSJ Bioreagents Company Detail
11.14.2 NSJ Bioreagents Business Overview
11.14.3 NSJ Bioreagents KI-67 Antibody Introduction
11.14.4 NSJ Bioreagents Revenue in KI-67 Antibody Business (2018-2024)
11.14.5 NSJ Bioreagents Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global KI-67 Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global KI-67 Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global KI-67 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global KI-67 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global KI-67 Antibody Market Share by Region (2018-2024)
Table 8. Global KI-67 Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global KI-67 Antibody Market Share by Region (2024-2029)
Table 10. KI-67 Antibody Market Trends
Table 11. KI-67 Antibody Market Drivers
Table 12. KI-67 Antibody Market Challenges
Table 13. KI-67 Antibody Market Restraints
Table 14. Global KI-67 Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global KI-67 Antibody Market Share by Players (2018-2024)
Table 16. Global Top KI-67 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in KI-67 Antibody as of 2022)
Table 17. Ranking of Global Top KI-67 Antibody Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by KI-67 Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players KI-67 Antibody Product Solution and Service
Table 21. Date of Enter into KI-67 Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global KI-67 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global KI-67 Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global KI-67 Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global KI-67 Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global KI-67 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global KI-67 Antibody Revenue Market Share by Application (2018-2024)
Table 29. Global KI-67 Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global KI-67 Antibody Revenue Market Share by Application (2024-2029)
Table 31. North America KI-67 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America KI-67 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America KI-67 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe KI-67 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe KI-67 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe KI-67 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific KI-67 Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific KI-67 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific KI-67 Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America KI-67 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America KI-67 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America KI-67 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa KI-67 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa KI-67 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa KI-67 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 46. BD Biosciences Company Detail
Table 47. BD Biosciences Business Overview
Table 48. BD Biosciences KI-67 Antibody Product
Table 49. BD Biosciences Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 50. BD Biosciences Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific KI-67 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Miltenyi Biotec Company Detail
Table 57. Miltenyi Biotec Business Overview
Table 58. Miltenyi Biotec KI-67 Antibody Product
Table 59. Miltenyi Biotec Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 60. Miltenyi Biotec Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck KI-67 Antibody Product
Table 64. Merck Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Miltenyi Biotec Company Detail
Table 67. Miltenyi Biotec Business Overview
Table 68. Miltenyi Biotec KI-67 Antibody Product
Table 69. Miltenyi Biotec Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 70. Miltenyi Biotec Recent Development
Table 71. Atlas Antibodies Company Detail
Table 72. Atlas Antibodies Business Overview
Table 73. Atlas Antibodies KI-67 Antibody Product
Table 74. Atlas Antibodies Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 75. Atlas Antibodies Recent Development
Table 76. Proteintech Company Detail
Table 77. Proteintech Business Overview
Table 78. Proteintech KI-67 Antibody Product
Table 79. Proteintech Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 80. Proteintech Recent Development
Table 81. FineTest Company Detail
Table 82. FineTest Business Overview
Table 83. FineTest KI-67 Antibody Product
Table 84. FineTest Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 85. FineTest Recent Development
Table 86. Synaptic Company Detail
Table 87. Synaptic Business Overview
Table 88. Synaptic KI-67 Antibody Product
Table 89. Synaptic Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 90. Synaptic Recent Development
Table 91. United States Biological Company Detail
Table 92. United States Biological Business Overview
Table 93. United States Biological KI-67 Antibody Product
Table 94. United States Biological Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 95. United States Biological Recent Development
Table 96. Bio-Rad Company Detail
Table 97. Bio-Rad Business Overview
Table 98. Bio-Rad KI-67 Antibody Product
Table 99. Bio-Rad Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 100. Bio-Rad Recent Development
Table 101. Beckman Coulter Company Detail
Table 102. Beckman Coulter Business Overview
Table 103. Beckman Coulter KI-67 Antibody Product
Table 104. Beckman Coulter Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 105. Beckman Coulter Recent Development
Table 106. Leica Biosystems Company Detail
Table 107. Leica Biosystems Business Overview
Table 108. Leica Biosystems KI-67 Antibody Product
Table 109. Leica Biosystems Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 110. Leica Biosystems Recent Development
Table 111. NSJ Bioreagents Company Detail
Table 112. NSJ Bioreagents Business Overview
Table 113. NSJ Bioreagents KI-67 Antibody Product
Table 114. NSJ Bioreagents Revenue in KI-67 Antibody Business (2018-2024) & (US$ Million)
Table 115. NSJ Bioreagents Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global KI-67 Antibody Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global KI-67 Antibody Market Share by Type: 2022 VS 2029
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global KI-67 Antibody Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global KI-67 Antibody Market Share by Application: 2022 VS 2029
Figure 7. Immunofluorescence Case Studies
Figure 8. Immunohistochemistry Frozen Case Studies
Figure 9. Immunohistochemistry Paraffin Case Studies
Figure 10. Western Blot Case Studies
Figure 11. Others Case Studies
Figure 12. KI-67 Antibody Report Years Considered
Figure 13. Global KI-67 Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global KI-67 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global KI-67 Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global KI-67 Antibody Market Share by Players in 2022
Figure 17. Global Top KI-67 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in KI-67 Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by KI-67 Antibody Revenue in 2022
Figure 19. North America KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America KI-67 Antibody Market Share by Country (2018-2029)
Figure 21. United States KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe KI-67 Antibody Market Share by Country (2018-2029)
Figure 25. Germany KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific KI-67 Antibody Market Share by Region (2018-2029)
Figure 33. China KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America KI-67 Antibody Market Share by Country (2018-2029)
Figure 41. Mexico KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa KI-67 Antibody Market Share by Country (2018-2029)
Figure 45. Turkey KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia KI-67 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. BD Biosciences Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 49. Miltenyi Biotec Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 50. Merck Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 51. Miltenyi Biotec Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 52. Atlas Antibodies Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 53. Proteintech Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 54. FineTest Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 55. Synaptic Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 56. United States Biological Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 57. Bio-Rad Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 58. Beckman Coulter Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 59. Leica Biosystems Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 60. NSJ Bioreagents Revenue Growth Rate in KI-67 Antibody Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed